WESPAC Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,277
Closed -$502K 88
2022
Q2
$502K Buy
5,277
+452
+9% +$46.8K 0.38% 56
2022
Q1
$568K Buy
4,825
+874
+22% +$98K 0.61% 69
2021
Q4
$512K Sell
3,951
-2,724
-41% -$318K 0.34% 95
2021
Q3
$756K Buy
+6,675
New +$762K 0.47% 76
2021
Q2
Sell
-2,454
Closed -$205K 112
2021
Q1
$205K Hold
2,454
0.15% 157
2020
Q4
$224K Buy
+2,454
New +$204K 0.17% 134
2020
Q1
Sell
-9,486
Closed -$738K 65
2019
Q4
$738K Sell
9,486
-150
-2% -$11.7K 0.72% 52
2019
Q3
$706K Buy
+9,636
New +$677K 0.7% 54
2018
Q4
Sell
-4,908
Closed -$285K 118
2018
Q3
$285K Buy
+4,908
New +$240K 0.17% 117
2018
Q2
Sell
-4,929
Closed -$229K 121
2018
Q1
$229K Buy
+4,929
New +$214K 0.14% 128

Other funds holding EW